Celanese completes EVA capacity expansion at acetyl chain facility in Edmonton

Celanese Corporation, a global specialty materials and chemical company, has announced the completion of an ultra-low capital project to repurpose existing manufacturing and infrastructure assets to unlock additional ethylene vinyl acetate (EVA) capacity at its Edmonton facility. The expansion supports significant growth in the Acetyl Chain’s downstream vinyls portfolio.

“The rapidly increasing demand for sustainable energy sources throughout the world, such as solar and wind power, continues to play an important role in global demand growth for EVA,” said Richard Jacobs, senior director, EVA polymers at Celanese.

“Demand for EVA in solar applications is anticipated to grow at a double-digit compounded annual rate through 2028, making the EVA industry one of the fastest growing products in our Acetyl Chain portfolio.”

The expansion provides approximately 35 percent incremental EVA capacity starting in the first quarter of 2023.

The Acetyl Chain’s reactor capabilities and unique footprint allow for a more customized approach to product manufacturing with the flexibility to produce a full range of EVA products to serve demand in growing solar applications, wire and cables, food packaging, medical devices, and drug delivery solutions. Celanese EVA products are sold under the product names including Ateva EVA and Ateva G Medical Grade.

Above: Ateva G EVA used for a dental application.

“We continue to strengthen Celanese as an industry leader in the acetyls and derivatives space,” said Mark Murray, senior vice president, Acetyl Chain.

“This EVA expansion enhances our downstream optionality to capture growth in high-value applications and to deliver on our commitment to be a preferred partner of our customers.”